Your browser doesn't support javascript.
Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study.
Zheng, Xueying; Luo, Sihui; Sun, Yong; Han, Mingfeng; Liu, Jian; Sun, Liangye; Zhang, Liangming; Ling, Ping; Ding, Yu; Jin, Tengchuan; Liu, Zhirong; Weng, Jianping.
  • Zheng X; The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • Luo S; The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • Sun Y; Key Laboratory for Medical and Health of the 13th Five-Year Plan, Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, China.
  • Han M; Fuyang No.2 People's Hospital, Fuyang 236015, China.
  • Liu J; Anqing Hospital Affiliated to Anhui Medical University (Anqing Municipal Hospital), Anqing 246003, China.
  • Sun L; Lu'an People's Hospital, Lu'an 237005, China.
  • Zhang L; Department of Infectious Disease, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • Ling P; The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • Ding Y; The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • Jin T; The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • Liu Z; Key Laboratory for Medical and Health of the 13th Five-Year Plan, Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, China.
  • Weng J; The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230001, China.
Natl Sci Rev ; 7(10): 1527-1539, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-1114859
ABSTRACT
In this population-based study, we identified 307 confirmed COVID-19 cases from massive surveillance, including 129 551 individuals screened at fever clinics or returning from Hubei and 3710 close contacts of confirmed COVID-19 patients. Among them, 17 patients were asymptomatic at initial clinical assessment. These asymptomatic patients on admission accounted for a small proportion of all patients (5.54%) with relatively weak transmissibility, and the detection rate was 0.35 per 100 close contacts. Moreover, the dynamics of symptoms of the 307 patients showed that the interval from symptom remission to the final negativity of viral nucleic acid was 5.0 days (interquartile range 2.0 to 11.0 days), with 14 patients (4.56%) having re-detectable viral RNA after discharge. Overall, our findings suggested asymptomatic carriers and presymptomatic patients only accounted for a small proportion of COVID-19 patients. Also, the asymptomatic phase during recovery from COVID-19 implied that negativity in viral RNA is necessary as a de-isolation criterion and follow-up is recommended.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Prognostic study Language: English Journal: Natl Sci Rev Year: 2020 Document Type: Article Affiliation country: NSR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Prognostic study Language: English Journal: Natl Sci Rev Year: 2020 Document Type: Article Affiliation country: NSR